75 research outputs found

    A detection method for latent circadian rhythm sleep-wake disorder

    Get PDF
    Background Individuals with typical circadian rhythm sleep-wake disorders (CRSWDs) have a habitual sleep timing that is desynchronized from social time schedules. However, it is possible to willfully force synchronisation against circadian-driven sleepiness, which causes other sleep problems. This pathology is distinguishable from typical CRSWDs and is referred to here as latent CRSWD (LCRSWD). Conventional diagnostic methods for typical CRSWDs are insufficient for detecting LCRSWD because sufferers have an apparently normal habitual sleep timing. Methods We first evaluated the reliability of circadian phase estimation based on clock gene expression using hair follicles collected at three time points without sleep interruption. Next, to identify detection criteria for LCRSWD, we compared circadian and sleep parameters according to estimated circadian phases, at the group and individual level, between subjects with low and high Pittsburgh Sleep Quality Index (PSQI) scores. To validate the reliability of identified detection criteria, we investigated whether the same subjects could be reproducibly identified at a later date and whether circadian amelioration resulted in sleep improvement. Findings We successfully validated the reliability of circadian phase estimation at three time points and identified potential detection criteria for individuals with LCRSWD attributed to delayed circadian-driven sleepiness. In particular, a criterion based on the interval between the times of the estimated circadian phase of clock gene expression and getting out of bed on work or school days was promising. We also successfully confirmed the reproducibility of candidate screening and sleep improvement by circadian amelioration, supporting the reliability of the detection criteria. Interpretation Although several limitations remain, our present study demonstrates a promising prototype of a detection method for LCRSWD attributed to delayed circadian-driven sleepiness. More extensive trials are needed to further validate this method

    肺高血圧症に対するトロンボキサン合成阻害作用をもった新規長期作用型プロスタサイクリンアゴニストの経口投与

    Get PDF
    BACKGROUND: Continuous administration of prostacyclin has improved the survival of patients with pulmonary arterial hypertension (PAH). However, this treatment has some problems, including its short duration of activity and difficult delivery. Therefore, we developed ONO-1301, an orally active, long-acting prostacyclin agonist with thromboxane synthase inhibitory activity. METHODS AND RESULTS: We investigated whether oral administration of ONO-1301 can both prevent and reverse monocrotaline (MCT)-induced PAH in rats. Rats were randomly assigned to receive repeated oral administration of ONO-1301 twice daily beginning either 1 or 8 days after subcutaneous injection of MCT. A control group received oral saline, and a sham group received a subcutaneous injection of saline instead of MCT. MCT-treated controls developed significant pulmonary hypertension. Treatment with ONO-1301 from day 1 or 8 significantly attenuated the increases in right ventricular systolic pressure and the increase in medial wall thickness of pulmonary arterioles. Kaplan-Meier survival curves demonstrated that the effect of ONO-1301 was equivalent to that of an endothelin receptor antagonist and a phosphodiesterase-5 inhibitor. A single oral dose of ONO-1301 increased plasma cAMP levels for up to 6h. Treatment with ONO-1301 significantly decreased urinary 11-dehydro-thromboxane B2 and increased the plasma hepatocyte growth factor concentration. CONCLUSIONS: Oral administration of ONO-1301 ameliorated PAH in rats, an effect that may occur through cAMP and hepatocyte growth factor.博士(医学)・乙1326号・平成26年3月17日日本循環器学会の許諾を得て登録(2014年6月6日付)ジャーナル公式サイト(日本循環器学会HP内):https://www.j-circ.or.jp/journal/公開サイト(J-STAGE):https://www.jstage.jst.go.jp/browse/circj

    Renormalization group analysis of the spin-gap phase in the one-dimensional t-J model

    Full text link
    We study the spin-gap phase in the one-dimensional t-J model, assuming that it is caused by the backward scattering process. Based on the renormalization group analysis and symmetry, we can determine the transition point between the Tomonaga-Luttinger liquid and the spin-gap phases, by the level crossing of the singlet and the triplet excitations. In contrast to the previous works, the obtained spin-gap region is unexpectedly large. We also check that the universality class of the transition belongs to the k=1k=1 SU(2) Wess-Zumino-Witten model.Comment: 4 pages(RevTeX), 5 figures(EPS), TITCMT-97-10, to appear in Phys. Rev. Let

    Spin-Gap Phases in Tomonaga-Luttinger Liquids

    Full text link
    We give the details of the analysis for critical properties of spin-gap phases in one-dimensional lattice electron models. In the Tomonaga-Luttinger (TL) liquid theory, the spin-gap instability occurs when the backward scattering changes from repulsive to attractive. This transition point is shown to be equivalent to that of the level-crossing of the singlet and the triplet excitation spectra, using the c=1 conformal field theory and the renormalization group. Based on this notion, the transition point between the TL liquid and the spin-gap phases can be determined with high-accuracy from the numerical data of finite-size clusters. We also discuss the boundary conditions and discrete symmetries to extract these excitation spectra. This technique is applied to the extended Hubbard model, the t-J model, and the t-J-J' model, and their phase diagrams are obtained. We also discuss the relation between our results and analytical solutions in weak-coupling and low-density limits.Comment: 14 pages(REVTeX), 9 figures(EPS), 1 table, To appear in PRB, Detailed paper of PRL 79 (1997) 3214 and JPSJ 67 (1998) 71

    Time-resolved serial femtosecond crystallography reveals early structural changes in channelrhodopsin

    Get PDF
    X線自由電子レーザーを用いて、光照射によるチャネルロドプシンの構造変化の過程を捉えることに成功. 京都大学プレスリリース. 2021-03-26.Channelrhodopsins (ChRs) are microbial light-gated ion channels utilized in optogenetics to control neural activity with light . Light absorption causes retinal chromophore isomerization and subsequent protein conformational changes visualized as optically distinguished intermediates, coupled with channel opening and closing. However, the detailed molecular events underlying channel gating remain unknown. We performed time-resolved serial femtosecond crystallographic analyses of ChR by using an X-ray free electron laser, which revealed conformational changes following photoactivation. The isomerized retinal adopts a twisted conformation and shifts toward the putative internal proton donor residues, consequently inducing an outward shift of TM3, as well as a local deformation in TM7. These early conformational changes in the pore-forming helices should be the triggers that lead to opening of the ion conducting pore

    Silencing of Carbohydrate Sulfotransferase 15 Hinders Murine Pulmonary Fibrosis Development

    No full text
    Pulmonary fibrosis is a progressive lung disorder characterized by interstitial fibrosis, for which no effective treatments are available. Chondroitin sulfate proteoglycan (CSPG) has been shown to be a mediator, but the specific component of glycosaminoglycan chains of CSPG has not been explored. We show that chondroitin sulfate E-type (CS-E) is involved in fibrogenesis. Small interfering RNA (siRNA) targeting carbohydrate sulfotransferase 15 (CHST15) was designed to inhibit CHST15 mRNA and its product, CS-E. CS-E augments cell contraction and CHST15 siRNA inhibits collagen production. We found that bleomycin treatment increased CHST15 expression in interstitial fibroblasts at day 14. CHST15 siRNA was injected intranasally on days 1, 4, 8, and 11, and CHST15 mRNA was significantly suppressed by day 14. CHST15 siRNA reduced lung CSPG and the grade of fibrosis. CHST15 siRNA repressed the activation of fibroblasts, as evidenced by suppressed expression of α smooth muscle actin (αSMA), connective tissue growth factor (CTGF), lysyl oxidase like 2 (LOXL2), and CC-chemokine ligand 2 (CCL2)/monocyte chemoattractant protein-1 (MCP-1). Inflammatory infiltrates in the bronchoalveolar lavage fluid (BALF) and interstitium were diminished by CHST15 siRNA. These results indicate a pivotal role for CHST15 in fibroblast-mediated lung fibrosis and suggest a possible new therapeutic role for CHST15 siRNA in pulmonary fibrosis. Keywords: bleomycin, chondroitin sulfate proteoglycans, pulmonary fibrosis, macrophages, fibroblasts, chondroitin sulfate, idiopathic pulmonary fibrosi
    corecore